Cited by 102Malaria Research and ControlPharmaceutical studies and practicesAntibiotics Pharmacokinetics and Efficacy

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria

Open access

Tarning, Joel, Rijken, Marcus J., McGready, Rose, Phyo, Aung Pyae, Hanpithakpong, Warunee, Day, Nicholas P. J., White, Nicholas J., Nosten, François, Lindegardh, Niklas·2012·Antimicrobial Agents and Chemotherapy

DOI 10.1128/aac.05756-11PMC PMC3318332

Open this paper in CoChat — free account

Abstract

Pregnant women are particularly vulnerable to malaria. The pharmacokinetic properties of antimalarial drugs are often affected by pregnancy, resulting in lower drug concentrations and a consequently higher risk of treatment failure. The objective of this study was to evaluate the population pharmacokinetic properties of piperaquine and dihydroartemisinin in pregnant and nonpregnant women with uncomplicated malaria. Twenty-four pregnant and 24 matched nonpregnant women on the Thai-Myanmar boarder were treated with a standard fixed oral 3-day treatment, and venous plasma concentrations of both drugs were measured frequently for pharmacokinetic evaluation. Population pharmacokinetics were evaluated with nonlinear mixed-effects modeling. The main pharmacokinetic finding was an unaltered total exposure to piperaquine but reduced exposure to dihydroartemisinin in pregnant compared to nonpregnant women with uncomplicated malaria. Piperaquine was best described by a three-compartment disposition model with a 45% higher elimination clearance and a 47% increase in relative bioavailability in pregnant women compared with nonpregnant women. The resulting net effect of pregnancy was an unaltered total exposure to piperaquine but a shorter terminal elimination half-life. Dihydroartemisinin was best described by a one-compartment disposition model with a 38% lower relative bioavailability in pregnant women than nonpregnant women. The resulting net effect of pregnancy was a decreased total exposure to dihydroartemisinin. The shorter terminal elimination half-life of piperaquine and lower exposure to dihydroartemisinin will shorten the posttreatment prophylactic effect and might affect cure rates. The clinical impact of these pharmacokinetic findings in pregnant women with uncomplicated malaria needs to be evaluated in larger series.

Integrity signals

Registry

Crossref · 10.1128/aac.05756-11

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Self-citation
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Bergstrand, M., Hooker, A. C., Wallin, J. E., & Karlsson, M. O. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9255-z · Cited by 1,435
Ways to Fit a PK Model with Some Data Below the Quantification Limit
Beal, S. L. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1012299115260 · Cited by 1,156
PsN-Toolkit—A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM
Lindbom, L., Pihlgren, P., & Jonsson, E. N. (2005) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2005.04.005 · Cited by 1,137
Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM
Jonsson, E. N., & Karlsson, M. O. (1998) · Computer Methods and Programs in Biomedicine · doi:10.1016/s0169-2607(98)00067-4 · Cited by 1,009
Perl-speaks-NONMEM (PsN) - a Perl module for NONMEM related programming
Lindbom, L., Ribbing, J., & Jonsson, E. (2004) · Comput. Methods Programs Biomed. · doi:10.1016/j.cmpb.2003.11.003 · Cited by 787
Drugs in Pregnancy
Koren, G., Pastuszak, A. L., & Ito, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381607 · Cited by 748
Pregnancy-Induced Changes in Pharmacokinetics
Anderson, G. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00001 · Cited by 650
Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions
Savić, R. M., & Karlsson, M. O. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9133-0 · Cited by 641
Malaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628

Show all 63 references

Research works printed but not linked: 1

WHO. 2010. World Health Organization guidelines for the treatment of malaria. WHO, Geneva, Switzerland.

Sorted by citations

Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review
Pariente, G., Leibson, T., Carls, A., Adams-Webber, T., Ito, S., & Koren, G. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002160 · Cited by 369
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Phyo, A. P., Jittamala, P., Nosten, F. H., Pukrittayakamee, S., Imwong, M., White, N. J., Duparc, S., Macintyre, F., Baker, M., & Möhrle, J. J. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00320-5 · Cited by 198
Self-citation
Malaria in pregnancy.
Takem, E. N., & D'Alessandro, U. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.010 · Cited by 185
Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
Bopp, S. E. R., Magistrado-Coxen, P., Wong, W., Schaffner, S. F., Mukherjee, A., Lim, P., Dhorda, M., Amaratunga, C., Woodrow, C. J., Ashley, E. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04104-z · Cited by 127
Self-citation
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis
Okell, L., Cairns, M. E., Griffin, J. T., Ferguson, N. M., Tärning, J., Jagoe, G., Hugo, P., Baker, M., D’Alessandro, U., Bousema, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms6606 · Cited by 100
Malaria
Plewes, K., Leopold, S. J., Kingston, H. W. F., & Dondorp, A. M. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2018.10.002 · Cited by 112
Dihydroartemisinin/Piperaquine
Keating, G. M. (2012) · Drugs · doi:10.2165/11203910-000000000-00000 · Cited by 102
Randomized, Open-Label Trial of Primaquine against Vivax Malaria Relapse in Indonesia
Sutanto, I., Tjahjono, B., Basri, H., Taylor, W. R. J., Putri, F. A., Meilia, R. A., Setiabudy, R., Nurleila, S., Ekawati, L. L., Elyazar, I., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01879-12 · Cited by 91
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis
Hoglund, R. M., Workman, L., Edstein, M. D., Thanh, N. X., Quang, N. N., Zongo, I., Ouédraogo, J., Borrmann, S., Mwai, L., Nsanzabana, C., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002212 · Cited by 82
Self-citation
Obstetric Pharmacokinetic Dosing Studies are Urgently Needed
McCormack, S. A., & Best, B. M. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00009 · Cited by 79
Malaria: an update on current chemotherapy
Visser, B. J., van Vugt, M., & Grobusch, M. P. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.944499 · Cited by 73
Treating Severe Malaria in Pregnancy: A Review of the Evidence
Kovacs, S. D., Rijken, M. J., & Stergachis, A. (2015) · Drug Safety · doi:10.1007/s40264-014-0261-9 · Cited by 66
Self-citation
Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination
Gerardin, J., Eckhoff, P., & Wenger, E. A. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0887-y · Cited by 68
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
Saito, M., Gilder, M. E., McGready, R. M., & Nosten, F. H. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1535593 · Cited by 58
Self-citation
Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
Hanboonkunupakarn, B., Ashley, E. A., Jittamala, P., Tärning, J., Pukrittayakamee, S., Hanpithakpong, W., Chotsiri, P., Wattanakul, T., Panapipat, S., Lee, S. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03704-14 · Cited by 52
Self-citation
Population Pharmacokinetic and Pharmacodynamic Modeling of Amodiaquine and Desethylamodiaquine in Women with Plasmodium vivax Malaria during and after Pregnancy
Tarning, J., Chotsiri, P., Jullien, V., Rijken, M. J., Bergstrand, M., Cammas, M., McGready, R., Singhasivanon, P., Day, N. P. J., White, N. J., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01242-12 · Cited by 51
Self-citation
Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda
Kloprogge, F., Piola, P., Dhorda, M., Muwanga, S., Turyakira, E., Apinan, S., Lindegårdh, N., Nosten, F. H., Day, N., White, N. J., et al. (2013) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.59 · Cited by 49
Self-citation
Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Sugiarto, P., Tjitra, E., Anstey, N. M., & Price, R. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084976 · Cited by 48
Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda
Tärning, J., Kloprogge, F., Dhorda, M., Jullien, V., Nosten, F. H., White, N. J., Guerin, P. J., & Piola, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-13 · Cited by 46
Self-citation
Population Pharmacokinetics of Intramuscular Artesunate in African Children With Severe Malaria: Implications for a Practical Dosing Regimen
Hendriksen, I., Mtove, G. A., Kent, A., Gesase, S., Reyburn, H., Lemnge, M. M., Lindegårdh, N., Day, N., von Seidlein, L., White, N. J., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.26 · Cited by 44
Self-citation
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy‐Associated Reduction of Dihydroartemisinin‐Piperaquine Exposure During Malaria Chemoprevention
Kajubi, R., Huang, L., Jagannathan, P., Chamankhah, N., Were, M., Ruel, T., Koss, C., Kakuru, A., Mwebaza, N., Kamya, M. R., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.664 · Cited by 44
Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women
Mutagonda, R. F., Kamuhabwa, A. A. R., Minzi, O., Massawe, S. N., Asghar, M., Homann, M. V., Färnert, A., & Aklillu, E. (2017) · Malaria Journal · doi:10.1186/s12936-017-1914-9 · Cited by 44
Treatment of uncomplicated and severe malaria during pregnancy
D’Alessandro, U., Hill, J., Tärning, J., Pell, C. L., Webster, J., Gutman, J., & Sevene, E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30065-3 · Cited by 46
A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan
Hoglund, R. M., Adam, I., Hanpithakpong, W., Ashton, M., Lindegårdh, N., Day, N., White, N. J., Nosten, F. H., & Tärning, J. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-398 · Cited by 44
Self-citation
Structure-switching aptamer sensors for the specific detection of piperaquine and mefloquine
Coonahan, E. S., Yang, K.-A., Pecic, S., Vos, M. D., Wellems, T. E., Fay, M. P., Andersen, J. F., Tärning, J., & Long, C. A. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe1535 · Cited by 45
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
Tarning, J., Kloprogge, F., Piola, P., Dhorda, M., Muwanga, S., Turyakira, E., Nuengchamnong, N., Nosten, F., Day, N. P., White, N. J., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-293 · Cited by 43
Self-citation
Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing
Ali, A. M., Penny, M. A., Smith, T. A., Workman, L., Sasi, P. G., Adjei, G. O., Aweeka, F. T., Kiechel, J., Jullien, V., Rijken, M. J., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02193-17 · Cited by 42
Self-citation
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
Hodel, E. M., Guidi, M., Zanolari, B., Mercier, T., Socheat, D., Kabanywanyi, A. M., Ariey, F., Buclin, T., Beck, H., Decosterd, L. A., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-235 · Cited by 41
Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria
Adam, I., Tärning, J., Lindegårdh, N., Mahgoub, H. M., McGready, R. M., & Nosten, F. H. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.11-0410 · Cited by 41
Self-citation
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Chotsiri, P., Zongo, I., Milligan, P. J., Compaoré, Y. D., Somé, A. F., Chandramohan, D., Hanpithakpong, W., Nosten, F. H., Greenwood, B. M., Rosenthal, P. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08297-9 · Cited by 41
Self-citation
Prevalence and risk factors associated with asymptomatic Plasmodium falciparum infection and anemia among pregnant women at the first antenatal care visit: A hospital based cross-sectional study in Kwale County, Kenya
Nyamu, G. W., Kihara, J. H., Oyugi, E. O., Omballa, V., El‐Busaidy, H., & Jeza, V. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239578 · Cited by 41
Population Pharmacokinetics, Tolerability, and Safety of Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine-Piperaquine in Pregnant and Nonpregnant Papua New Guinean Women
Benjamin, J. M., Moore, B. R., Salman, S., Page‐Sharp, M., Tawat, S., Yadi, G., Lorry, L., Siba, P. M., Batty, K. T., Robinson, L. J., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00326-15 · Cited by 43
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin–piperaquine in healthy volunteers
Chotsiri, P., Wattanakul, T., Hoglund, R. M., Hanboonkunupakarn, B., Pukrittayakamee, S., Blessborn, D., Jittamala, P., White, N. J., Day, N., & Tärning, J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13372 · Cited by 40
Self-citation
Treatment of Malaria in Pregnancy
Tärning, J. (2016) · New England Journal of Medicine · doi:10.1056/nejme1601193 · Cited by 41
Evaluation of the QT effect of a combination of piperaquine and a novel anti‐malarial drug candidate OZ439, for the treatment of uncomplicated malaria
Darpö, B., Ferber, G., Siegl, P. K. S., Laurijssens, B. E., Macintyre, F., Toovey, S., & Duparc, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12680 · Cited by 35
Opposite malaria and pregnancy effect on oral bioavailability of artesunate – a population pharmacokinetic evaluation
Kloprogge, F., McGready, R. M., Phyo, A. P., Rijken, M. J., Hanpithakpon, W., Than, H. H., Hlaing, N., Zin, N. T., Day, N., White, N. J., et al. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12660 · Cited by 33
Self-citation
Model‐Informed Dose Optimization in Pregnancy
Chaphekar, N., Caritis, S. N., & Venkataramanan, R. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1777 · Cited by 32
Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso
Valéa, I., Tinto, H., Traoré‐Coulibaly, M., Toe, L. C., Lindegårdh, N., Tärning, J., Geertruyden, J. V., D’Alessandro, U., Davies, G., & Ward, S. A. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku154 · Cited by 32
Population Pharmacokinetic Assessment of the Effect of Food on Piperaquine Bioavailability in Patients with Uncomplicated Malaria
Tärning, J., Lindegårdh, N., Lwin, K. M., Annerberg, A., Kiricharoen, L., Ashley, E. A., White, N. J., Nosten, F. H., & Day, N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02318-13 · Cited by 30
Self-citation
Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: a protocol to investigate safety, efficacy and adherence
Schallig, H. D. F. H., Tinto, H., Sawa, P., Kaur, H., Duparc, S., Ishengoma, D. S., Magnussen, P., Alifrangis, M., & Sutherland, C. J. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2017-000371 · Cited by 30
Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness
Kay, K., Hodel, E. M., & Hastings, I. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00482-15 · Cited by 29
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa
Onyamboko, M. A., Hoglund, R. M., Lee, S. J., Kabedi, C., Kayembe, D. K., Badjanga, B. B., Turner, G. D. H., Jackson, N. V., Tärning, J., McGready, R. M., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01140-19 · Cited by 27
Self-citation
Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine
Savić, R. M., Jagannathan, P., Kajubi, R., Huang, L., Zhang, N., Were, M., Kakuru, A., Muhindo, M. K., Mwebaza, N., Wallender, E. K., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy218 · Cited by 25
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand
Tärning, J., Thana, P., Phyo, A. P., Lwin, K. M., Hanpithakpong, W., Ashley, E. A., Day, N., Nosten, F. H., & White, N. J. (2014) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2014.29 · Cited by 24
Self-citation
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
Kloprogge, F., Jullien, V., Piola, P., Dhorda, M., Muwanga, S., Nosten, F. H., Day, N. P., White, N. J., Guerin, P. J., & Tärning, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku228 · Cited by 24
Self-citation
Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women
Moore, B. R., Benjamin, J. M., Auyeung, S. O., Salman, S., Yadi, G., Griffin, S., Page‐Sharp, M., Batty, K. T., Siba, P. M., Müeller, I., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12910 · Cited by 24
New insight-guided approaches to detect, cure, prevent and eliminate malaria
Kumar, S., Kumari, R., & Pandey, R. (2014) · PROTOPLASMA · doi:10.1007/s00709-014-0697-x · Cited by 23
Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers msp-1 , msp-2 , and glurp
Jones, S. P., Kay, K., Hodel, E. M., Chy, S., Mbituyumuremyi, A., Uwimana, A., Ménard, D., Felger, I., & Hastings, I. M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00590-19 · Cited by 23
The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region
Unger, H. W., Acharya, S., Arnold, L., Wu, C., van Eijk, A. M., Gore‐Langton, G. R., ter Kuile, F. O., Lufele, E., Chico, R. M., Price, R. N., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00415-1 · Cited by 22
Diagnosis and management of malaria in the intensive care unit
Akafity, G., Kumi, N., & Ashong, J. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.09.002 · Cited by 22
Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model
Walker, L. A., & Sullivan, D. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02499-16 · Cited by 21
Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia
Vanachayangkul, P., Lon, C., Spring, M., Sok, S., Ta-aksorn, W., Kodchakorn, C., Pann, S.-T., Chann, S., Ittiverakul, M., Sriwichai, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02000-16 · Cited by 20
Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria
Das, J. L., Rulisa, S., de Vries, P. J., Mens, P. F., Kaligirwa, N., Agaba, S., Tärning, J., Karlsson, M. O., & Dorlo, T. P. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00518-18 · Cited by 20
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention
Bergstrand, M., Nosten, F. H., Lwin, K. M., Karlsson, M. O., White, N. J., & Tärning, J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005311 · Cited by 19
Self-citation
Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin‐Piperaquine for Uncomplicated Malaria
Sambol, N. C., Yan, L., Creek, D. J., McCormack, S. A., Arinaitwe, E., Bigira, V., Wanzira, H., Kakuru, A., Jw, T., Lindegårdh, N., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.104 · Cited by 18
Self-citation
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
Jamsen, K. M., Duffull, S. B., Tärning, J., Lindegårdh, N., White, N. J., & Simpson, J. A. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-143 · Cited by 18
Self-citation
The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review
Burger, R. J., Visser, B. J., Grobusch, M. P., & van Vugt, M. (2016) · Malaria Journal · doi:10.1186/s12936-016-1160-6 · Cited by 18
The application of physiologically based pharmacokinetic modelling to assess the impact of antiretroviral‐mediated drug–drug interactions on piperaquine antimalarial therapy during pregnancy
Olafuyi, O., Coleman, M. D., & Badhan, R. K. S. (2017) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2087 · Cited by 18
Pharmacology of Antimalarial Drugs, Current Anti-malarials
Na‐Bangchang, K., & Karbwang, J. (2019) · Springer eBooks · doi:10.1007/978-1-4614-8326-7_149 · Cited by 17
Intravenous artesunate plus oral dihydroartemisinin–piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia
Sikora, S. A., Poespoprodjo, J. R., Kenangalem, E., Lampah, D. A., Sugiarto, P., Laksono, I. S., Ahmad, R. A., & Murhandarwati, E. E. H. (2019) · Malaria Journal · doi:10.1186/s12936-019-3085-3 · Cited by 16
Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy
Chotsiri, P., Gutman, J., Ahmed, R., Poespoprodjo, J. R., Syafruddin, D., Khairallah, C., Asih, P. B. S., L’lanziva, A., Otieno, K., Kariuki, S., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01150-20 · Cited by 19
Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges
Patel, K., Simpson, J. A., Batty, K. T., Zaloumis, S. G., & Kirkpatrick, C. M. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12288 · Cited by 15
Ethics, regulation, and beyond: the landscape of research with pregnant women
Saénz, C., Cheah, P. Y., van der Graaf, R., Henry, L. M., & Mastroianni, A. C. (2017) · Reproductive Health · doi:10.1186/s12978-017-0421-3 · Cited by 15
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia
Das, J. L., Dondorp, A. M., Nosten, F. H., Phyo, A. P., Hanpithakpong, W., Ringwald, P., Lim, P., White, N. J., Karlsson, M. O., Bergstrand, M., et al. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0141-1 · Cited by 13
Self-citation
State of Artemisinin and Partner Drug Susceptibility in Plasmodium falciparum Clinical Isolates from Colombia
Montenegro, L. M., Salas, B. D. L., Neal, A., Tobón-Castaño, A., Fairhurst, R. M., & Lopera-Mesa, T. M. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0148 · Cited by 12
Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations
Sugiarto, S. R., Davis, T. M. E., & Salman, S. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1391212 · Cited by 11
Teratogen update: Malaria in pregnancy and the use of antimalarial drugs in the first trimester
Clark, R. L. (2020) · Birth Defects Research · doi:10.1002/bdr2.1798 · Cited by 10
Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study
Sambol, N. C., Tappero, J. W., Arinaitwe, E., & Parikh, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154623 · Cited by 10
Treatment regimens for pregnant women with falciparum malaria
Moore, B. R., Salman, S., & Davis, T. M. E. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1202758 · Cited by 11
Pharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challenges
Moore, B. R., & Davis, T. M. E. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1526923 · Cited by 9
Statistical Power Calculations for Mixed Pharmacokinetic Study Designs Using a Population Approach
Kloprogge, F., Simpson, J. A., Day, N. P. J., White, N. J., & Tärning, J. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9641-4 · Cited by 8
Self-citation
Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women
Hughes, E. A., Imperial, M. Z., Wallender, E. K., Kajubi, R., Huang, L., Jagannathan, P., Zhang, N., Kakuru, A., Natureeba, P., Mwima, M. W., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01013-20 · Cited by 8
Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria
Wattanakul, T., Baker, M., Möhrle, J., McWhinney, B. C., Hoglund, R. M., McCarthy, J. S., & Tärning, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-20 · Cited by 8
Interspecies Allometric Scaling of Antimalarial Drugs and Potential Application to Pediatric Dosing
Senarathna, S. M. D. K. G., & Batty, K. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02538-14 · Cited by 7
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
Schalkwijk, S. J., ter Heine, R., Colbers, A. P. H., Huitema, A. D. R., Denti, P., Dooley, K. E., Capparelli, E. V., Best, B. M., Cressey, T. R., Greupink, R., et al. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0642-9 · Cited by 7
Population pharmacokinetics of mefloquine given as a 3-day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai–Myanmar border
Hoglund, R. M., Ruengweerayut, R., & Na‐Bangchang, K. (2018) · Malaria Journal · doi:10.1186/s12936-018-2466-3 · Cited by 7
Pharmacokinetic Evaluation in Pregnancy—Current Status and Future Considerations: Workshop Summary
Guinn, D., Şahin, L., Fletcher, E. P., Choi, S., Johnson, T., Dinatale, M., Baisden, K. W., Sun, W., Pillai, V. C., Morales, J. P., et al. (2023) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2230 · Cited by 6
Dihydroartemisinin–Piperaquine Combination in the Treatment of Uncomplicated Plasmodium falciparum Malaria: Update on Clinical Failures in Africa and Tools for Surveillance
Delandre, O., Pradines, B., & Javelle, É. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226828 · Cited by 7
Pharmacokinetic studies of antimalarials: recent developments
Davis, T. M. E. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1108190 · Cited by 6
Inter-Species Pharmacokinetic Modeling and Scaling for Drug Repurposing of Pyronaridine and Artesunate
Kang, D. W., Kim, J. H., Kim, K., Cho, S.-J., Choi, G.-W., & Cho, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136998 · Cited by 5
Pharmacometric and statistical considerations for dose optimization
Chotsiri, P., Yodsawat, P., Hoglund, R. M., Simpson, J. A., & Tärning, J. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13271 · Cited by 5
Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects
Liu, L., Ding, Y., Jiao, Z., Wu, M., Li, C., Liu, J., Liu, C., Hu, Y., Li, Q., & Zhang, H. (2019) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.717 · Cited by 5
Use of quantitative pharmacology tools to improve malaria treatments
Davis, T. M. E., Moore, B. R., Salman, S., Page‐Sharp, M., Batty, K. T., & Manning, L. A. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1129273 · Cited by 5
Pharmacokinetics of piperaquine and its association with intermittent malaria preventive therapy outcomes during pregnancy
Mlugu, E. M., Minzi, O., Johansson, M., Kamuhabwa, A. A. R., & Aklillu, E. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00762-6 · Cited by 4
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB
Losada, J. C., Triana, H. J., Vanegas, E., Caro-Rojas, A., Rodríguez‐López, A., Espejo-Mojica, A. J., & Alméciga-Díaz, C. J. (2024) · ChemBioChem · doi:10.1002/cbic.202400081 · Cited by 3
In vivo antimalarial effect of 1-hydroxy-5,6,7-trimethoxyxanthone isolated from Mammea siamensis T. Anders. flowers: pharmacokinetic and acute toxicity studies
Chaniad, P., Chukaew, A., Na-Ek, P., Yusakul, G., Chuaboon, L., Phuwajaroanpong, A., Plirat, W., Konyanee, A., Septama, A. W., & Punsawad, C. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04427-z · Cited by 3
Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections
Ding, J., Hoglund, R. M., Tagbor, H. K., Tinto, H., Valéa, I., Mwapasa, V., Kalilani‐Phiri, L., Geertruyden, J. V., Nambozi, M., Mulenga, M., et al. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13211 · Cited by 3
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial
Birgersson, S., Valéa, I., Tinto, H., Traoré‐Coulibaly, M., Toe, L. C., Hoglund, R. M., Geertruyden, J. V., Ward, S. A., D’Alessandro, U., Äbelö, A., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14849.1 · Cited by 3
Cohort Profile: the SMRU Refugee and Migrant Pregnancy Study in Western Thailand and Eastern Myanmar
McGready, R., J White, N., Nosten, F. H., & Collaborators, S. R. A. M. P. S. (2026) · Wellcome Open Research · doi:10.12688/wellcomeopenres.25582.2 · Cited by 2
Self-citation
Malaria – Current Treatment Options
Virginia, D. M., Shegokar, R., & Pathak, Y. (2023) · Malarial Drug Delivery Systems · doi:10.1007/978-3-031-15848-3_4 · Cited by 1
Safety, efficacy and pharmacokinetics profile of antimalarial drugs in pregnancy : pharmacoepidemiology studies
Mosha, D. (2014) · edoc (University of Basel) · doi:10.5451/unibas-006310194
Pharmacokinetics of artemisinin derivatives in rats, healthy volunteers and patients
Birgersson, S. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Population Pharmacokinetic-Pharmacodynamic Modelling of Antimalarial Treatment
Hoglund, R. M. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Utilisation des tests moléculaires pour la détection rapide des bactériémies à Staphylococcus aureus résistants à la méticilline
Margat, E. (2012) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2013.02.003
Evaluation of efficacy and safety of artesunate and its active metabolite, dihydroartemisinin, in streptozotocin-induced diabetes rats by blood pharmacokinetic analysis
Fukushima, K., Uchimura, Y., Okada, A., & Sugioka, N. (2014) · Interactive Medicinal Chemistry · doi:10.7243/2053-7107-2-1
An Overview of Pharmacokinetic Considerations for the Use of Artemisinin-Based Combinations in Three Unique Populations
Wilby, K. J., Pawluk, S. A., & Nasr, Z. G. (2016) · International Journal of Pharmacokinetics · doi:10.4155/ipk-2016-0013
PHARMACOLOGY AND PHARMACODYNAMICS OF SELECTED ANTIMALARIALS AGAINST P. falciparum GAMETOCYTES
Saif, A. (2017) · University of Liverpool · doi:10.17638/03005700
Clinical needs assessment to inform development of a new assay to detect antimalarial drugs in patient samples: A case study
Coonahan, E. S., Amaratunga, C., Long, C. A., & Tärning, J. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002087
A Comprehensive Review on the Pharmacokinetics and Bioanalysis of Piperaquine
Xie, Y., Zhang, W., Rui, Z., Dai, Y., Xing, J., & Han, J. H. (2025) · Current Drug Metabolism · doi:10.2174/0113892002374755250613064601
Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV
Stoeger, L., Mischlinger, J., Nhampossa, T., Mombo‐Ngoma, G., Esen, M., Tchouatieu, A.-M., Brunet, M., Mendes, A., Mbadinga, L. B. D., Gamberini, S., et al. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00337-26

Authors: Tarning, J., Rijken, M. J., McGready, R., Phyo, A. P., Hanpithakpong, W., Day, N. P. J., White, N. J., Nosten, F., & Lindegardh, N.
Affiliations: Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Shoklo Malaria Research Unit (TH)
Mahidol University (TH)
ORCID: Rijken, Marcus J.
McGready, Rose
Phyo, Aung Pyae
Hanpithakpong, Warunee
Day, Nicholas P. J.
White, Nicholas J.
Nosten, François
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 2012-04
Volume: 56
Issue: 4
Pages: 1997-2007
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.05756-11
PMC: PMC3318332
OpenAlex: W2141478039
Cited by: 102
References: 63
Citations by year: 2026: 3 · 2025: 1 · 2024: 7 · 2023: 5 · 2021: 2 · 2020: 7 · 2019: 8 · 2018: 9 · 2017: 12 · 2016: 7 · 2015: 11 · 2014: 16 · 2013: 6 · 2012: 8
FWCI: 12.67
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Bill and Melinda Gates Foundation
Wellcome Trust (089275, 093956, 093956/Z/10/Z)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords: dihydroartemisinin, piperaquine, population pharmacokinetics, pregnancy, uncomplicated malaria, antimalarial drugs, relative bioavailability, elimination clearance, elimination half-life, one-compartment model, Thai-Myanmar border
MeSH terms: Adolescent, Adult, Antimalarials, Body Weight, Myanmar, Chromatography, High Pressure Liquid, Female, Half-Life, Humans, Malaria, Middle Aged, Piperazines, Population, Predictive Value of Tests, Pregnancy, Quinolines, Software, Thailand, Pregnancy Complications, Parasitic, Nonlinear Dynamics, Area Under Curve, Artemisinins, Tandem Mass Spectrometry, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks